⌘K

Home/Filings/4/0001493152-21-015888

4//SEC Filing

Amin Dipti 4

Accession 0001493152-21-015888

CIK 0000876343other

View on SEC.gov Company Profile

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 6:26 PM ET

Size

5.4 KB

Accession

0001493152-21-015888

Insider Transaction Report

Form 4

Period: 2021-07-01

Lineage Cell Therapeutics, Inc.LCTX

Director

Transactions

Award
Stock Option (right to buy)
2021-07-01+50,000→ 50,000 total
Exercise: $2.86Exp: 2031-07-01→ Common Shares (50,000 underlying)

Footnotes (1)

[F1]Will vest and become exercisable on July 1, 2022, subject to the reporting person's continuous service with the issuer.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Lineage Cell Therapeutics, Inc.

CIK 0000876343

Entity typeother

Related Parties

1

filerCIK 0001856708

Filing Metadata

Form type: 4
Filed: Jun 30, 8:00 PM ET
Accepted: Jul 1, 6:26 PM ET
Size: 5.4 KB

View on SEC.gov